Topas Therapeutics Signs Multi-Year Research and Option Agreement with Lilly Focused on Immune Tolerance
August 22, 2017
Work will utilize Topas’ novel approach for antigen-specific tolerance induction Lilly has option to in-license and further develop drug candidates produced under the collaboration